SPONSOR
Universidade Federal de Sergipe
Total Trials
1
Recruiting
1
Phases
Phase 4
Universidade Federal de Sergipe is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Intravenous Anesthesia, Cholelithiasis.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universidade Federal de Sergipe
How many clinical trials has Universidade Federal de Sergipe sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Universidade Federal de Sergipe, of which 1 are actively recruiting participants. These trials cover conditions including Intravenous Anesthesia, Cholelithiasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universidade Federal de Sergipe research focus on?
Universidade Federal de Sergipe clinical trials span Intravenous Anesthesia, Cholelithiasis. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universidade Federal de Sergipe clinical trial?
To participate in a Universidade Federal de Sergipe trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universidade Federal de Sergipe trials with current recruitment status updated daily.
Clinical Trials by Universidade Federal de Sergipe
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology